A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The study was published in JAMA Network Open.
5 Steps to Retain Ownership for Mid-Size Healthcare Organizations
Sridhar Yerramreddy, CEO & Founder of Steer Health The healthcare landscape is continually evolving, and for mid-sized healthcare organizations, this evolution presents both challenges and
November 10, 2023